Travis Tidwell, DPM
Podiatrist · Waterloo, IANPI 1043627292
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (50.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Stryker accounts for 60.4% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $11,126 and has fallen 85.3% since, to $1,633 in 2025. Among podiatrist clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 210 payments — averaging $155.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$20K
- International Life Sciences$12K
- Organogenesis Inc.$537
- Johnson & Johnson$110
- Zimmer Biomet$87
- Melinta Therapeutics, LLC$56
- plus $181 from 9 others
What the payments were for
- Consulting fees$10,80033%
- Travel & lodging$16,31050%
- Food & beverage$5,44817%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 141 | $19,666 |
| International Life Sciences | 5 | $11,919 |
| Organogenesis Inc. | 42 | $537 |
| Johnson & Johnson | 4 | $110 |
| Zimmer Biomet | 3 | $87 |
| Melinta Therapeutics, LLC | 4 | $56 |
| Smith+Nephew | 2 | $42 |
| Boston Scientific | 2 | $29 |
| Integra Lifesciences Corporation | 1 | $19 |
| Paragon 28, Inc. | 1 | $19 |
| AbbVie | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $15 |
| Misonix Inc | 1 | $15 |
| Osiris Therapeutics Inc. | 1 | $13 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$32,557 in reported general payments places this provider in the 95th percentile of 94 podiatrist providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 69 | $478 |
| Gabapentin | 31 | $343 |
| Terbinafine Hcl | 22 | $261 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $98 |
| Cephalexin | 13 | $78 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Waterloo
- Ronald KaneWaterloo$11K
- Colleen LoweWaterloo$5K
- Stephen MeyerWaterloo$3K
- Levi AndrewsWaterloo$755
- Paul DaytonAnkeny$9.4M
- Mindi DaytonAnkeny$333K
- Eric BarpWest Des Moines$149K
- Eric TempleWest Des Moines$19K
- Eric JensenCarroll$17K
- Eric ReeseWest Des Moines$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.